The article is a study of cardiovascular health, looking into how a given disease or therapy affects cardiovascular health. Researchers conducted a study to look at how various factors, including drugs, lifestyle, or medical therapies, affect heart disease, heart attack, or cardiovascular function as a whole. The study tracked a cohort of cardiovascular patients over a period of time to see how their condition progressed and if the treatments were working.
This case report describes a rare and extremely malignant tumor named Primary Cardiac Lymphoma (PCL), which occurs in the heart. Because of the rarity of cardiac cancer, its diagnosis generally presents major challenges. The report describes the case of a 67-year-old male patient who initially came in for medical assessment after experiencing recurrent attacks of syncope.
This case report describes a rare and extremely malignant tumor named Primary Cardiac Lymphoma (PCL), which occurs in the heart. Because of the rarity of cardiac cancer, its diagnosis generally presents major challenges. The report describes the case of a 67-year-old male patient who initially came in for medical assessment after experiencing recurrent attacks of syncope.
The study investigates the feasibility, safety, and effectiveness of a high-intensity exercise programme for patients with hypertrophic cardiomyopathy (HCM). Historically, individuals with HCM were advised to avoid intense physical activity due to concerns about sudden cardiac death. However, recent research suggests that exercise might be safer than previously thought, prompting the need for further investigation.
The study explores the correlation between blood glucose level and early signs of a cardiac disease called aortic valve calcification (AVC) in middle-aged people. AVC is a disease in which calcium deposits in the aortic valve harden the valve, and it may eventually lead to aortic stenosis (AS). Without treatment, the disease is hazardous, as it affects the blood flow from the heart.
The American College of Cardiology and the American Heart Association have recently issued new guidelines for the management of patients with acute coronary syndromes (ACS), such as heart attacks. The guidelines merge earlier recommendations for both forms of ACS—STEMI (severe) and NSTEMI—into one set of guidelines.
